American Heart Association Archive — Page 7 of 10

Manual blood pressure monitor with a blue cuff, round pressure gauge, black inflation bulb, and attached stethoscope on a white background.
November 13, 2017

Salt, inflammation and hypertension

Vanderbilt researchers have identified a pathway that links excess sodium, inflammation and hypertension.

Illustration of two translucent cells joined during division, with several smaller cells floating against a blue background.
November 10, 2017

A lipid’s role in cell division

Lipids in the plasma membrane regulate the position of the contractile ring that is required for cell division, Vanderbilt researchers have discovered.

Kathy Gould and graduate student Chloe Snider pose beside laboratory equipment and a computer displaying a microscopy image.
November 9, 2017

Advanced imaging tools reveal architecture of cell division machinery

Using super-resolution microscopy tools in the Nikon Center of Excellence, Vanderbilt investigators have determined the molecular architecture of the contractile ring machinery that functions during cell division — a process that is essential for life.

Crowd of Greater Nashville Heart Walk participants in blue shirts gathers outdoors, with one person holding a sign reading “2017 Greater Nashville Heart Walk,” “VANDERBILT STROKE TEAM,” and “NO MORE.”
October 19, 2017

Heart Walk 2017

An estimated 8,000 participants enjoyed a sunny sky, warm temperature and live music during the 25th annual Greater Nashville Heart Walk on Saturday, Oct. 14.

Crowd of Heart Walk participants, many wearing red, walks past Vanderbilt Children’s Hospital; a stroller is visible in the foreground.
October 5, 2017

2017 Greater Nashville Heart Walk takes place Oct. 14

The 2017 Greater Nashville Heart Walk hits the Vanderbilt campus on Saturday, Oct. 14.

Stylized blue illustration of human lungs with branching airways.
August 17, 2017

Block estrogen to treat lung disease

Based on findings from Vanderbilt investigators and others, clinical trials of estrogen inhibition for pulmonary arterial hypertension have recently been approved and funded by the National Institutes of Health.